Tickerplace logo

Tickerplace

Viridian Therapeutics, Inc. logo

VRDNViridian Therapeutics, Inc.

VRDN Stock Price, Valuation & Chart | Viridian Therapeutics, Inc.

Compare
$23.030-0.13 (-0.56%)

At close · 01 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyVRDN intrinsic valueVRDN calculated fair value vs price
OverviewFinancialsDividendsRatios

VRDN Historical price chart

VRDN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization2.61B
PE Ratio-6.83
EPS-3.37
Trading Volume998.38K
Today's High/Low23.33/22.9
Dividend Yield0.00
52 Week High/Low34.29/13.18
Shares Outstanding113.29M
VRDN Financial Statement
VRDN Analyst ratings
VRDN Analysis & performance metrics

VRDN Company profile

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal…

VRDN Management team

VRDN Frequently asked questions

What is Viridian Therapeutics, Inc. (VRDN) Stock Price?

Current stock price of Viridian Therapeutics, Inc. (VRDN) stock is $23.030. The stock price is -0.56% lower in the session. The intraday range can be seen from this page. Volume of Viridian Therapeutics, Inc. (VRDN) stock is 998.38K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Viridian Therapeutics, Inc. (VRDN) stock price going up or down today?

The stock price of Viridian Therapeutics, Inc. (VRDN) can change with earnings, company news, and overall market sentiment. Viridian Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Viridian Therapeutics, Inc. stock expensive at its current price?

Whether Viridian Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VRDN on this page is -6.83. EPS on this page is -3.37. Compare those figures with peers and growth expectations before deciding if the current Viridian Therapeutics, Inc. price is justified.

How has the stock price of Viridian Therapeutics, Inc. (VRDN) performed historically?

Historical performance for Viridian Therapeutics, Inc. (VRDN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VRDN reacted to past earnings and market events.

Should I buy Viridian Therapeutics, Inc. (VRDN) stock, at this price?

Buying Viridian Therapeutics, Inc. (VRDN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.